U.S. RESEARCH ROUNDUP-Carmax, Mirion Technologies, Valmont Industries

Reuters
Sep 26
U.S. RESEARCH ROUNDUP-Carmax, <a href="https://laohu8.com/S/MIR">Mirion</a> Technologies, Valmont Industries

Sept 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, including Carmax, Mirion Technologies and Valmont Industries, on Friday.

HIGHLIGHTS

* Carmax Inc KMX.N: Oppenheimer cuts to perform from outperform

* First Horizon Corp FHN.N: D.A. Davidson initiates coverage with neutral rating

* Mirion Technologies Inc MIR.N: JP Morgan initiates coverage with overweight rating

* Riot Platforms Inc RIOT.O: JP Morgan raises to overweight from neutral

* Valmont Industries Inc VMI.N: JP Morgan initiates coverage with overweight rating

Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Allarity Therapeutics ALLR.O: Ascendiant Capital Markets raises PT to $9.25 from $9

* Allegiant Travel Co ALGT.O: UBS raises target price to $65 from $52

* American Airlines Group Inc AAL.O: UBS raises target price to $13 from $12

* Applovin Corp APP.O: Piper Sandler raises target price to $740 from $500

* Applovin Corp APP.O: UBS raises target price to $810 from $540

* Atmos Energy Corp ATO.N: Mizuho raises target price to $170 from $164

* BNY BK.N: Citigroup raises target price to $113 from $103

* BP BP.N: BofA Global Research raises price objective to $35 from $34

* CalMaine Foods Inc CALM.O: Stephens cuts target price to $105 from $115

* Camping World Holdings Inc CWH.N: Citigroup raises target price to $22 from $21

* Carmax Inc KMX.N: JP Morgan cuts target price to $50 from $65

* Carmax Inc KMX.N: Needham cuts target price to $60 from $92

* Carmax Inc KMX.N: Oppenheimer cuts to perform from outperform

* Carmax Inc KMX.N: RBC cuts target price to $59 from $81

* Carmax Inc KMX.N: Truist Securities cuts target price to $47 from $74

* CG Oncology Inc CGON.O: JP Morgan raises target price to $47 from $41

* Cidara Therapeutics Inc CDTX.O: H.C. Wainwright raises target price to $110 from $74

* Ciena Corp CIEN.N: Rosenblatt Securities raises target price to $175 from $127.5

* Ciena Corp CIEN.N: Rosenblatt Securities raises to buy from neutral

* Cipher Mining Inc CIFR.O: JP Morgan raises target price to $12 from $6

* Cleanspark Inc CLSK.O: JP Morgan cuts target price to $14 from $15

* Cleanspark Inc CLSK.O: JP Morgan cuts to neutral from overweight

* Costco Wholesale Corp COST.O: Bernstein raises target price to $1,140 from $1,137

* Costco Wholesale Corp COST.O: JP Morgan cuts target price to $1050 from $1160

* Costco Wholesale Corp COST.O: Morgan Stanley cuts target price to $1130 from $1225

* Costco Wholesale Corp COST.O: Truist Securities cuts PT to $1,033 from $1,042

* Crinetics Pharmaceuticals Inc CRNX.O: Baird raises target price to $62 from $58

* Dave Inc DAVE.O: Citizens raises target price to $300 from $280

* Duke Energy Corp DUK.N: Jefferies cuts target price to $134 from $141

* Duke Energy Corp DUK.N: Jefferies cuts to hold from buy

* First Horizon Corp FHN.N: D.A. Davidson initiates coverage with neutral rating

* First Horizon Corp FHN.N: D.A. Davidson initiates coverage with target price $24

* First Merchants Corp FRME.O: KBW raises target price to $50 from $49

* First Merchants Corp FRME.O: Raymond James cuts to market perform from outperform

* Fox Corp FOXA.O: BofA Global Research raises price objective to $70 from $65

* Fox Corp FOXA.O: JP Morgan raises target price to $61 from $57

* FreeportMcmoran Inc FCX.N: Stifel cuts target price to $48 from $57

* Frontier Group Holdings Inc ULCC.O: UBS raises target price to $5 from $3.5

* Guardant Health Inc GH.O: Canaccord Genuity raises target price to $75 from $65

* Guardian Pharmacy Services Inc GRDN.N: Truist Securities raises PT to $30 from $28

* H.B. Fuller FUL.N: Deutsche Bank cuts target price to $70 from $72

* H.B. Fuller Company FUL.N: Citigroup cuts target price to $62 from $70

* H.B. Fuller Company FUL.N: Seaport Research Partners raises to buy from neutral

* Harmony Biosciences HRMY.O: Mizuho cuts target price to $35 from $50

* Immuneering Corp IMRX.O: Chardan Capital Markets raises target price to $20 from $13

* Integral Ad Science Holding Corp IAS.O: Stifel cuts target price to $10.3 from $14

* Integral Ad Science Holding Corp IAS.O: Stifel cuts to hold from buy

* Klaviyo Inc KVYO.N: Baird cuts target price to $39 from $44

* Klaviyo Inc KVYO.N: Piper Sandler cuts target price to $50 from $55

* Klaviyo Inc KVYO.N: Stephens cuts target price to $43 from $45

* Laureate Education Inc LAUR.O: Jefferies raises target price to $36 from $28

* Levi Strauss & Co LEVI.N: Barclays raises target price to $26 from $24

* Lightpath Technologies Inc LPTH.O: H.C. Wainwright raises target price to $8 from $7

* Live Nation Entertainment Inc LYV.N: Benchmark raises target price to $190 from $180

* Macerich Co MAC.N: BofA Global Research raises to buy from neutral

* Macerich Co MAC.N: BofA Global Research raises price objective to $23 from $19

* Marathon Digital Holdings Inc MARA.O: JP Morgan cuts target price to $20 from $22

* McKesson Corp MCK.N: JP Morgan raises target price to $853 from $821

* Microsoft MSFT.O: Morgan Stanley raises target price to $625.00 from $582.00

* Mirion Technologies Inc MIR.N: JP Morgan initiates coverage with overweight rating

* Mirion Technologies Inc MIR.N: JP Morgan initiates coverage with target price $28

* Morgan Stanley MS.N: Citigroup raises target price to $155 from $130

* One Gas Inc OGS.N: Mizuho raises target price to $86 from $77

* One Gas Inc OGS.N: Mizuho raises to outperform from neutral

* Oracle Corp ORCL.N: Bernstein raises target price to $364 from $363

* Pure Storage Inc PSTG.N: Needham raises target price to $100 from $85

* Pure Storage Inc PSTG.N: Susquehanna raises target price to $100 from $75

* Ralph Lauren Corp RL.N: JP Morgan raises target price to $430 from $423

* RAPT Therapeutics Inc RAPT.O: Leerink Partner raises target price to $37 from $16

* RAPT Therapeutics Inc RAPT.O: Leerink Partner raises to outperform from market perform

* Riot Platforms Inc RIOT.O: JP Morgan raises target price to $19 from $15

* Riot Platforms Inc RIOT.O: JP Morgan raises to overweight from neutral

* Rollins Inc ROL.N: JP Morgan initiates coverage with overweight rating

* Rollins Inc ROL.N: JP Morgan initiates coverage with target price $70

* Spyre Therapeutics Inc SYRE.O: Deutsche Bank initiates coverage with buy rating

* Spyre Therapeutics Inc SYRE.O: Deutsche Bank initiates coverage with target price $43

* TD Synnex SNX.N: Raymond James raises target price to $175 from $160

* TD Synnex SNX.N: RBC raises target price to $180 from $165

* TD Synnex Corporation SNX.N: Morgan Stanley raises PT to $181.00 from $173.00

* Tesla Inc TSLA.O: Deutsche Bank raises target price to $435 from $345

* Tesla Inc TSLA.O: Wedbush raises target price to $600 from $500

* Thor Industries Inc THO.N: BMO raises target price to $115 from $105

* Thor Industries Inc THO.N: Citigroup raises target price to $122 from $112

* Thor Industries Inc THO.N: Jefferies raises target price to $100 from $92

* United Airlines Holdings Inc UAL.O: UBS raises target price to $131 from $114

* United States Antimony Corp UAMY.A: H.C. Wainwright raises PT to $8.5 from $4.5

* United Therapeutics Corp UTHR.O: RBC initiates coverage with outperform rating

* United Therapeutics Corp UTHR.O: RBC initiates coverage with target price $569

* UPS UPS.N: BofA Global Research cuts price objective to $81 from $83

* Valmont Industries Inc VMI.N: JP Morgan initiates coverage with overweight rating

* Valmont Industries Inc VMI.N: JP Morgan initiates coverage with target price $480

* Warner Bros Discovery Inc WBD.O: KeyBanc cuts to sector weight from overweight

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10